290 related articles for article (PubMed ID: 12577848)
1. [Time course changes in the count of peripheral granulocytes in children with acquired aplastic anemias treated with antithymocyte globulin, cyclosporin A and granulocytic colony stimulating factor].
Bogacheva NIu; Novichkova GA; Litvinov DV; Khachatrian LA; Baĭdil'dina DD; Shneĭder MM; Suntsova EV; Skorobogatova EV; Maschan AA
Ter Arkh; 2002; 74(12):71-7. PubMed ID: 12577848
[TBL] [Abstract][Full Text] [Related]
2. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
[TBL] [Abstract][Full Text] [Related]
3. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
Pongtanakul B; Das PK; Charpentier K; Dror Y
Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor.
Dinçol G; Aktan M; Diz-Küçükkaya R; Yavuz S; Nalçaci M; Oztürk S; Palanduz S; Doğan O; Ağan M
Am J Hematol; 2007 Sep; 82(9):783-6. PubMed ID: 17506070
[TBL] [Abstract][Full Text] [Related]
5. Early hemopoietic progenitors in the peripheral blood of patients with severe aplastic anemia (SAA) after treatment with antilymphocyte globulin (ALG), cyclosporin-A and G-CSF.
Bacigalupo A; Piaggio G; Podestà M; Tong J; Pitto A; Figari O; Benvenuto F; Vassallo F; Tedone E; Grassia L; Van Lint MT; Gualandi F; Hoffman R
Haematologica; 1997; 82(2):133-7. PubMed ID: 9175313
[TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up.
Saracco P; Quarello P; Iori AP; Zecca M; Longoni D; Svahn J; Varotto S; Del Vecchio GC; Dufour C; Ramenghi U; Bacigalupo A; Locasciulli A;
Br J Haematol; 2008 Jan; 140(2):197-205. PubMed ID: 18173756
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of immunosuppressive therapy for children with aplastic anemia].
Wang YC; Yin CY; Feng L; Wang CM; Ma LN; Wei YW; Sheng GY
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jan; 14(1):33-7. PubMed ID: 22289749
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment.
Meidlinger P; Knöbl P; Jäger U; Gisslinger H; Pabinger I; Weltermann A; Lechner K; Geissler K
Ann Hematol; 1999 Jul; 78(7):299-304. PubMed ID: 10466441
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine.
Fang JP; Xu HG; Huang SL; Chen C; Huang K
Pediatr Hematol Oncol; 2006; 23(1):45-50. PubMed ID: 16326412
[TBL] [Abstract][Full Text] [Related]
11. [Successful combined therapy with ATG, cyclosporin and G-CSF for both liver dysfunction and bone marrow failure in hepatitis-associated aplastic anemia].
Adachi Y; Usuki K; Kazama H; Iki S; Matsuya S; Urabe A
Rinsho Ketsueki; 2001 Sep; 42(9):691-5. PubMed ID: 11680980
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia.
Kojima S; Hibi S; Kosaka Y; Yamamoto M; Tsuchida M; Mugishima H; Sugita K; Yabe H; Ohara A; Tsukimoto I
Blood; 2000 Sep; 96(6):2049-54. PubMed ID: 10979946
[TBL] [Abstract][Full Text] [Related]
13. Long-term interleukin-3 and intensive immunosuppression in the treatment of aplastic anemia.
Raghavachar A; Ganser A; Freund M; Heimpel H; Herrmann F; Schrezenmeier H
Cytokines Mol Ther; 1996 Dec; 2(4):215-23. PubMed ID: 9384707
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of acquired aplastic anemia in children and unexpected frequency of varicella-zoster virus association: a single-center study.
Yetgin S; Kuşkonmaz B; Aytaç S; Cetin M
Turk J Pediatr; 2008; 50(4):342-8. PubMed ID: 19014047
[TBL] [Abstract][Full Text] [Related]
15. Recovery of hematopoietic progenitor cells in patients with severe aplastic anemia who obtained good clinical response with a combination therapy of immunosuppressive agents and recombinant human granulocyte colony-stimulating factor.
Matsuo Y; Iwanaga M; Mori H; Yoshida S; Kawaguchi Y; Yakata Y; Murata K; Nagai K; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M
Int J Hematol; 2000 Jul; 72(1):37-43. PubMed ID: 10979207
[TBL] [Abstract][Full Text] [Related]
16. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Di Bona E; Rodeghiero F; Bruno B; Gabbas A; Foa P; Locasciulli A; Rosanelli C; Camba L; Saracco P; Lippi A; Iori AP; Porta F; De Rossi G; Comotti B; Iacopino P; Dufour C; Bacigalupo A
Br J Haematol; 1999 Nov; 107(2):330-4. PubMed ID: 10583220
[TBL] [Abstract][Full Text] [Related]
17. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
[TBL] [Abstract][Full Text] [Related]
18. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
Chang MH; Kim KH; Kim HS; Jun HJ; Kim DH; Jang JH; Kim K; Jung CW
Eur J Haematol; 2010 Feb; 84(2):154-9. PubMed ID: 19912311
[TBL] [Abstract][Full Text] [Related]
19. Severe aplastic anaemia--complete response to antilymphocyte globulin and cyclosporin.
Jones-Lecointe A; Murphy A; Charles W; Daisley H; Pitt-Miller P
West Indian Med J; 1999 Dec; 48(4):238-9. PubMed ID: 10639849
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of aplastic anemia with anti-thymocyte globulin and cyclosporine].
Ohnishi S; Nakagawa M; Kobayashi N; Ogasawara M; Kiyama Y; Naohara T; Higa T; Kasai M
Rinsho Ketsueki; 1998 Sep; 39(9):640-4. PubMed ID: 9796396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
